These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 16337231

  • 21. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    El-Kabbani O, Carbone V, Darmanin C, Oka M, Mitschler A, Podjarny A, Schulze-Briese C, Chung RP.
    J Med Chem; 2005 Aug 25; 48(17):5536-42. PubMed ID: 16107153
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
    Zhao HT, Hazemann I, Mitschler A, Carbone V, Joachimiak A, Ginell S, Podjarny A, El-Kabbani O.
    J Med Chem; 2008 Mar 13; 51(5):1478-81. PubMed ID: 18284183
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. High-resolution crystal structure of manganese peroxidase: substrate and inhibitor complexes.
    Sundaramoorthy M, Youngs HL, Gold MH, Poulos TL.
    Biochemistry; 2005 May 03; 44(17):6463-70. PubMed ID: 15850380
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY, Sall DJ, Briggs SL, Clawson DK, Zhang M, Smith GF, Schevitz RW.
    Protein Sci; 2000 Jan 03; 9(1):29-36. PubMed ID: 10739244
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX, Cousido-Siah A, Mitschler A, Farrés J, Parés X, Podjarny A.
    Chem Biol Interact; 2013 Feb 25; 202(1-3):178-85. PubMed ID: 23295227
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hydrogen bonding interactions between aldose reductase complexed with NADP(H) and inhibitor tolrestat studied by molecular dynamics simulations and binding assay.
    Lee YS, Hodoscek M, Kador PF, Sugiyama K.
    Chem Biol Interact; 2003 Feb 01; 143-144():307-16. PubMed ID: 12604217
    [Abstract] [Full Text] [Related]

  • 39. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S, Stieglitz KA, Eldo J, Xia J, Cardia JP, Kantrowitz ER.
    Biochemistry; 2006 Aug 22; 45(33):10062-71. PubMed ID: 16906764
    [Abstract] [Full Text] [Related]

  • 40. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M, Koellner G, Yokomatsu T, Shibuya S, Bzowska A.
    Acta Crystallogr D Biol Crystallogr; 2004 Aug 22; 60(Pt 8):1417-24. PubMed ID: 15272165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.